Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT06972615
Recruiting
Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy
Phase 2 · Argentina · 1 site
Registry update: 28 May 2026
2025-522119-41-00
Recruiting
Effect of Empagliflozin in patients with eGFR between 10 and 20 ml/min/1.73m2 - EMPA [10-20]
Phase 3 · France · 1 site
Registry update: 5 Mar 2026
NCT07598370
Recruiting
A Study of LY3439539 in Participants With Alzheimer's Disease
Phase 1 · Australia, New Zealand, Singapore, United States · 16 sites
Registry update: 4 Nov 2026
NCT07590635
Recruiting
eCardiacRehab - a Hybrid Patient-Centered eHealth Programme
Not applicable · Norway · 1 site
Registry update: 23 Jun 2026
NCT07559019
Recruiting
Safety and Preliminary Activity of BI115 in Advanced SCLC
Phase 1 · China · 1 site
Registry update: 4 Jun 2026
NCT07413939
Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
Phase 2/3 · Argentina, Austria, Australia, Belgium, Brazil, Canada, Chile, China, Czechia, Germany, Spain, France, United Kingdom, Hungary, Israel, Italy, South Korea, New Zealand, Poland, Portugal, Thailand, Taiwan, Ukraine, United States, South Africa · 219 sites
Registry update: 5 Nov 2026
NCT07230808
Recruiting
Digitally Delivered Child Obesity Prevention for Parents in Home Visiting Programs
Not applicable · United States · 1 site
Registry update: 6 Jul 2026
NCT06681363
Recruiting
Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital
Not applicable · France · 1 site
Registry update: 29 May 2026
NCT07637448
Recruiting
EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC
Phase 2 · China · 1 site
Registry update: 9 Jun 2026
NCT04520139
Recruiting
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Phase 1/2 · United States · 1 site
Registry update: 17 Jul 2026
NCT07522099
Recruiting
Chinese Adults With Kidney Disease
Phase 2 · China · 9 sites
Registry update: 3 Sept 2026
NCT07322887
Recruiting
A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease
Phase 2 · Netherlands · 1 site
Registry update: 17 Aug 2026
NCT07250646
Recruiting
A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
Phase 1 · United States · 3 sites
Registry update: 20 Jul 2026
2025-521702-18-00
Recruiting
A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
Phase 1 · Germany, Denmark, Spain, France, Portugal · 10 sites
Registry update: 15 Sept 2026
NCT07666074
Recruiting
AI-Based Prediction of Difficult Airway in Bariatric Surgery
Not applicable · 1 site
Registry update: 24 Jun 2026
NCT07564414
Recruiting
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Phase 3 · Argentina, Austria, Australia, Belgium, Bulgaria, Canada, Czechia, Spain, France, Greece, Hungary, Italy, Netherlands, Poland, Portugal, Romania, Slovakia, United States, South Africa · 295 sites
Registry update: 30 Sept 2026
Conflicting statuses (not updated in the registry for 1 month)
NCT07758582
Recruiting
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Diabetic Retinopathy in a Random Sample of Retinal Fundus Photographs
Not applicable · Greece · 1 site
Registry update: 11 Aug 2026
NCT07027124
Recruiting
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
Phase 2 · United States · 1 site
Registry update: 7 Oct 2026
NCT07422480
Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
Phase 3 · Argentina, Australia, Belgium, Bulgaria, Brazil, Switzerland, Germany, Spain, France, United Kingdom, Greece, Hungary, Ireland, India, Italy, Japan, South Korea, Lithuania, Mexico, Malaysia, Netherlands, Norway, Poland, Romania, Thailand, Türkiye, Taiwan, United States · 165 sites
Registry update: 6 Nov 2026
NCT07479979
Recruiting
Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
Phase 1/2 · United States · 1 site
Registry update: 31 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.